These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18661667)

  • 1. Regarding "Management of antitubercular drug-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal".
    Anupa KC; Bista D
    Kathmandu Univ Med J (KUMJ); 2005; 3(3):310. PubMed ID: 18661667
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal.
    Shakya R; Rao BS; Shrestha B
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):45-9. PubMed ID: 16401944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
    P V K; Palaian S; Ojha P; P R S
    Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hepatotoxicity of antitubercular agents].
    Alegre Martín J; Fernández de Sevilla T
    An Med Interna; 1992 Nov; 9(11):523-5. PubMed ID: 1467398
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of MDR-TB: is hepatotoxicity a problem?
    Loddenkemper R; Schaberg T
    Int J Tuberc Lung Dis; 2012 May; 16(5):571. PubMed ID: 22507929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
    Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
    Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis in children with tuberculosis: a case report and review of the literature.
    Sanchez-Codez M; Hunt WG; Watson J; Mejias A
    BMC Pulm Med; 2020 Jun; 20(1):173. PubMed ID: 32546255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents].
    Horsmans Y; Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1990; 14(12):919-24. PubMed ID: 2289669
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of hyperacute hepatotoxicity in response to tuberculosis therapy.
    Hercus CG; Khoo JK; Jones TE
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1709-10. PubMed ID: 23131275
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity of antituberculous drugs.
    Rao NK; Wadia RS; Karve SR; Grant KB
    J Assoc Physicians India; 1982 May; 30(5):295-8. PubMed ID: 7169440
    [No Abstract]   [Full Text] [Related]  

  • 12. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
    Ungo JR; Jones D; Ashkin D; Hollender ES; Bernstein D; Albanese AP; Pitchenik AE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1871-6. PubMed ID: 9620920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatotoxicity caused by isoniazid or by paracetamol].
    Andrade RJ; Lucena MI; Melgarejo F; García-Escaño MD
    Gastroenterol Hepatol; 1998; 21(6):314-5. PubMed ID: 9711017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rational use of hepato-protectants in the prophylaxis and treatment of anti-tuberculosis drug-induced hepatotoxicity].
    Gu J; Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):767-9. PubMed ID: 24433806
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers.
    Burman WJ; Reves RR
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1112-3. PubMed ID: 11673194
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver and antitubercular drug therapy].
    Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA
    Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse drug effects on the liver in patients with tuberculosis].
    Polunina TE; Polunin VI; Grishin VK
    Voen Med Zh; 1987 Oct; (10):67-8. PubMed ID: 3433693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinic and pathogenesis of drug hepatitis].
    Mardare G
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(1):43-5. PubMed ID: 25591247
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of anti-tuberculosis drug-induced hepatotoxicity.
    Tahaoğlu K; Ataç G; Sevim T; Tärün T; Yazicioğlu O; Horzum G; Gemci I; Ongel A; Kapakli N; Aksoy E
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):65-9. PubMed ID: 11263519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.